Browse by author
Lookup NU author(s): Professor Mike Catt
Full text is not currently available for this publication.
Methods, devices and test kits for monitoring the ovulation cycle, involve testing the body fluid, e.g. urinary, concentration of one or more analytes. Preferably estrone-3-glucuronide and luteinizing hormone are both measured, and a reference concentration for E3G is established at about day 6 of the current cycle. Preferably, disposable testing devices are used, in conjunction with a relatively permanent electronic reader/monitor. The number of "daily" tests required per month can be minimized.
Inventor(s): Catt M, Cunningham CR, Mundill PHC, Prior ME, Wilson S, Zhang ZG
Publication type: Patent
Publication status: Published
Print publication date: 17/09/2002
Assignee: Inverness Medical Switzerland GmbH, Zug, Switzerland
Source Publication Date: 17 September 2002